Keyphrases
Colon Cancer
100%
Adjuvant Therapy
100%
Carmofur
100%
Individual Patient Data Meta-analysis
100%
Overall Survival
57%
Disease-free Survival
57%
Meta-analysis
42%
Surgery Alone
42%
Adjuvant Chemotherapy
28%
5-year Survival
28%
Randomized Clinical Trial
28%
Confidence Interval
28%
Hazard Ratio
28%
Patient-centered
28%
Patient Survival
14%
Clinical Trials
14%
Clinical Analysis
14%
Colon Cancer Patients
14%
Inclusion Criteria
14%
5-year Follow-up
14%
Overall Survival Rate
14%
Pooled Analysis
14%
Analytical Strategy
14%
Intention-to-treat
14%
Individual Patient Data
14%
Medicine and Dentistry
Adjuvant Therapy
100%
Meta-Analysis
100%
Patient-Data
100%
Carmofur
100%
Colon Carcinoma
100%
Overall Survival
71%
Disease Free Survival
71%
Survival Rate
28%
Adjuvant Chemotherapy
28%
Randomized Clinical Trial
28%
Hazard Ratio
28%
Malignant Neoplasm
14%
Clinical Trial
14%
Intention-to-Treat Analysis
14%
Pooled Analysis
14%
Nursing and Health Professions
Meta Analysis
100%
Carmofur
100%
Patient Coding
100%
Adjuvant Therapy
100%
Colon Carcinoma
100%
Overall Survival
71%
Disease Free Survival
71%
Adjuvant Chemotherapy
28%
Survival Rate
28%
Confidence Interval
28%
Hazard Ratio
28%
Malignant Neoplasm
14%
Intention to Treat Analysis
14%
Chemotherapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Colon Carcinoma
100%
Carmofur
100%
Overall Survival
71%
Disease Free Survival
71%
Chemotherapy
28%
Survival Rate
28%
Randomized Clinical Trial
28%
Clinical Trial
14%
Malignant Neoplasm
14%